Emergent BioSolutions Reports Second Quarter 2024 Financial Results
Go back to Emergent BioSolutions Reports Second Quarter 2024 Financial Results| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.89 +0.39 (5.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.50 | 52 Week High | $44.38 | |||
| Open | $7.52 | 52 Week Low | $24.47 | |||
| Day High | $7.92 | P/E | 394.50 | |||
| Day Low | $7.42 | EPS | $0.02 | |||
| Volume | 861,703 | |||||

